Antiviral Effects of Virazole in Chronic Hepatitis B Surface Antigen-Seropositive Chimpanzees
AUTOR(ES)
Denes, Alexander E.
RESUMO
Virazole (Ribavirin, ICN 1229), a broad-spectrum, antiviral chemotherapeutic agent was used to treat two adult chronically hepatitis B surface antigen (HBs Ag)-seropositive chimpanzees. No significant change in serum hepatitis B surface antigen was noted and no adverse reactions were observed. The role of viral replication in the chronic carrier state of hepatitis B is discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=429791Documentos Relacionados
- Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen.
- Hepatitis B surface antigen-specific cell-mediated immune responses in human chronic hepatitis B surface antigen carriers.
- Protection of chimpanzees from type B hepatitis by immunization with woodchuck hepatitis virus surface antigen.
- delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees.
- Assessment of the infectivity of corneal buttons taken from hepatitis B surface antigen seropositive donors.
